The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Saad Mark E since year 2005.
The trader's CIK number is 1295913.
At the time of this reporting, Saad Mark E is the Chief Financial Officer of Cytori Therapeutics, Inc. .
(stock ticker symbol XMPA).
See this page for all insider trading activities at Cytori Therapeutics, Inc. .
Stock purchases, sales, and option exercises reported by insider Saad Mark E since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-08-12
CYTX
Cytori Therapeutics, Inc.
Purchase
15,000
6.69
100,315
2006-09-05
CYTX
Cytori Therapeutics, Inc.
Purchase
1,850
5.08
9,396
2006-09-01
CYTX
Cytori Therapeutics, Inc.
Purchase
1,550
5.31
8,224
2006-08-31
CYTX
Cytori Therapeutics, Inc.
Purchase
750
5.48
4,106
2006-08-29
CYTX
Cytori Therapeutics, Inc.
Purchase
800
5.22
4,177
2006-08-30
CYTX
Cytori Therapeutics, Inc.
Purchase
750
5.42
4,067
2006-08-25
CYTX
Cytori Therapeutics, Inc.
Purchase
800
4.99
3,994
2006-08-28
CYTX
Cytori Therapeutics, Inc.
Purchase
800
5.20
4,157
2006-08-23
CYTX
Cytori Therapeutics, Inc.
Purchase
850
4.28
3,637
2006-08-24
CYTX
Cytori Therapeutics, Inc.
Purchase
850
4.62
3,929
2006-08-21
CYTX
Cytori Therapeutics, Inc.
Purchase
883
4.52
3,991
2006-08-22
CYTX
Cytori Therapeutics, Inc.
Purchase
1,617
4.27
6,908
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Saad Mark E
(Chief Financial Officer of Cytori Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
